(Q36960508)

17 August 2017

1 reference

title

The potential of topical DNA vaccines adjuvanted by cytokines (English)

1 reference

17 August 2017

1

Julianna Lisziewicz

1 reference

17 August 2017

Sandra A Calarota

2

1 reference

17 August 2017

Franco Lori

series ordinal

3

1 reference

17 August 2017

language of work or name

English

0 references

publication date

1 October 2007

1 reference

Expert Opinion on Biological Therapy

17 August 2017

published in

1 reference

17 August 2017

volume

7

1 reference

17 August 2017

issue

10

1 reference

17 August 2017

page(s)

1563-1574

1 reference

DNA vaccines against human immunodeficiency virus type 1 in the past decade

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Protection against influenza virus challenge by topical application of influenza DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The gene gun: current applications in cutaneous gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Intradermal ballistic delivery of micro-particles into excised human skin for pharmaceutical applications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Increased DNA vaccine delivery and immunogenicity by electroporation in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Increased gene expression and inflammatory cell infiltration caused by electroporation are both important for improving the efficacy of DNA vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Improved genetic immunization via micromechanical disruption of skin-barrier function and targeted epidermal delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Microneedles for transdermal drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Minimally invasive cutaneous delivery of macromolecules and plasmid DNA via microneedles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Induction of potent human immunodeficiency virus type 1-specific T-cell-restricted immunity by genetically modified dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

APC-targeted immunization for the treatment of HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

DermaVir: a novel topical vaccine for HIV/AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Direct transfection and activation of human cutaneous dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Comparison of the CD8+ T cell responses and antitumor effects generated by DNA vaccine administered through gene gun, biojector, and syringe

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Induction of antigen-specific CD8+ T cells, T helper cells, and protective levels of antibody in humans by particle-mediated administration of a hepatitis B virus DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Cutaneous transfection and immune responses to intradermal nucleic acid vaccination are significantly enhanced by in vivo electropermeabilization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Enhanced delivery of naked DNA to the skin by non-invasive in vivo electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Smallpox DNA vaccine delivered by novel skin electroporation device protects mice against intranasal poxvirus challenge.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Enhancement of DNA vaccine potency in rhesus macaques by electroporation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

HIV-1 prophylactic vaccine comprised of topical DermaVir prime and protein boost elicits cellular immune responses and controls pathogenic R5 SHIV162P3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Langerhans cell migration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Cutaneous vaccination: the skin as an immunologically active tissue and the challenge of antigen delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Human and murine dermis contain dendritic cells. Isolation by means of a novel method and phenotypical and functional characterization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Effector and memory T-cell differentiation: implications for vaccine development

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Lineage relationship and protective immunity of memory CD8 T cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Central memory and effector memory T cell subsets: function, generation, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Dramatic rise in plasma viremia after CD8(+) T cell depletion in simian immunodeficiency virus-infected macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Cytotoxic T cell responses to multiple conserved HIV epitopes in HIV-resistant prostitutes in Nairobi

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

CD8(+) lymphocytes respond to different HIV epitopes in seronegative and infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Intracellular trafficking and transgene expression of viral and non-viral gene vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Latent infection of CD4+ T cells provides a mechanism for lifelong persistence of HIV-1, even in patients on effective combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

HIV-1-specific CD4+ T cells are detectable in most individuals with active HIV-1 infection, but decline with prolonged viral suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Vaccine-induced CD8+ central memory T cells in protection from simian AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Cross-reactive protection against influenza A virus by a topically applied DNA vaccine encoding M gene with adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Enhancement of human immunodeficiency virus type 1-DNA vaccine potency through incorporation of T-helper 1 molecular adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The role of cytokine DNAs as vaccine adjuvants for optimizing cellular immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The relevance of cytokines for development of protective immunity and rational design of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The role of CpG motifs in immunostimulation and gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Transcutaneous immunization with combined cholera toxin and CpG adjuvant protects against Chlamydia muridarum genital tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Granulocyte/macrophage colony-stimulating factor and interleukin 1 mediate the maturation of murine epidermal Langerhans cells into potent immunostimulatory dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Enhancement of protective humoral (Th2) and cell-mediated (Th1) immune responses against herpes simplex virus-2 through co-delivery of granulocyte-macrophage colony-stimulating factor expression cassettes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin-2 receptor gamma chain: a functional component of the interleukin-7 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The interleukin-2 receptor gamma chain: its role in the multiple cytokine receptor complexes and T cell development in XSCID

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin 15: biology and relevance to human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Diverse functions of IL-2, IL-15, and IL-7 in lymphoid homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The biology of interleukin-2 and interleukin-15: implications for cancer therapy and vaccine design

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

The IL-2/IL-2 receptor system: a current overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Intranasal administration of human immunodeficiency virus type-1 (HIV-1) DNA vaccine with interleukin-2 expression plasmid enhances cell-mediated immunity against HIV-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Modulation of antigen-specific humoral responses in rhesus macaques by using cytokine cDNAs as DNA vaccine adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Augmentation of immune responses to HIV-1 and simian immunodeficiency virus DNA vaccines by IL-2/Ig plasmid administration in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

DNA vaccination of infants in the presence of maternal antibody: a measles model in the primate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Induction of PSA-specific CTLs and anti-tumor immunity by a genetic prostate cancer vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin 7 is produced by murine and human keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin 7 is produced by human intestinal epithelial cells and regulates the proliferation of intestinal mucosal lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Overexpression of interleukin (IL)-7 leads to IL-15-independent generation of memory phenotype CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Selective expression of the interleukin 7 receptor identifies effector CD8 T cells that give rise to long-lived memory cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin-12 (IL-12) enhancement of the cellular immune response against human immunodeficiency virus type 1 env antigen in a DNA prime/vaccinia virus boost vaccine regimen is time and dose dependent: suppressive effects of IL-12 boost are mediate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Co-immunization with plasmid IL-12 generates a strong T-cell memory response in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

A dose sparing effect by plasmid encoded IL-12 adjuvant on a SIVgag-plasmid DNA vaccine in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Comparative ability of plasmid IL-12 and IL-15 to enhance cellular and humoral immune responses elicited by a SIVgag plasmid DNA vaccine and alter disease progression following SHIV(89.6P) challenge in rhesus macaques.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Subsets of memory cytotoxic T lymphocytes elicited by vaccination influence the efficiency of secondary expansion in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Control of homeostasis of CD8+ memory T cells by opposing cytokines.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

IL-15 expression plasmid enhances cell-mediated immunity induced by an HIV-1 DNA vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Coimmunization with an optimized IL-15 plasmid results in enhanced function and longevity of CD8 T cells that are partially independent of CD4 T cell help.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Coadministration of HIV vaccine vectors with vaccinia viruses expressing IL-15 but not IL-2 induces long-lasting cellular immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Systemic administration of IL-15 augments the antigen-specific primary CD8+ T cell response following vaccination with peptide-pulsed dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

IL-15 is superior to IL-2 in the generation of long-lived antigen specific memory CD4 and CD8 T cells in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

A CD4(+) T-cell immune response to a conserved epitope in the circumsporozoite protein correlates with protection from natural Plasmodium falciparum infection and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Durable human memory T cells quantifiable by cultured enzyme-linked immunospot assays are induced by heterologous prime boost immunization and correlate with protection against malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Enhanced T cell-mediated protection against malaria in human challenges by using the recombinant poxviruses FP9 and modified vaccinia virus Ankara

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Interleukin 15 skews monocyte differentiation into dendritic cells with features of Langerhans cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Safety of a GM-CSF adjuvant-plasmid DNA malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Expression kinetics of the interleukin-2/immunoglobulin (IL-2/Ig) plasmid cytokine adjuvant.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Epidermal Langerhans Cells Are Dispensable for Humoral and Cell-Mediated Immunity Elicited by Gene Gun Immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

SIV DNA vaccine co-administered with IL-12 expression plasmid enhances CD8 SIV cellular immune responses in cynomolgus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

IL-15 enhances survival and function of HIV-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

Vaccination onto bare skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14712598.7.10.1563

10.1517/14712598.7.10.1563

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference